Search - tctmd.com

Displaying 41 - 60 of 194

Sort: Relevancy | Date

News Conference News TCT 2019

TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More

Shelley Wood

September 19, 2019

News Conference News TCT 2018

Prosthetic Valve Endocarditis Rate Similarly Low for TAVR vs SAVR

TCT Daily Staff

September 28, 2018

News Opinion Editor's Corner TCT 2018

TCT 2018, Day Two: COAPT Prompts Round of Applause, Plus New Valve Insights

Shelley Wood

September 23, 2018

News Daily News TCT 2018

High Mortality but Durable Results With Valve-in-Valve TAVR

Michael O'Riordan

September 23, 2018

Presentation TCT 2018

PARTNER VALVE-IN-VALVE: Late Follow-up After Treatment of Failing Surgical Aortic Bioprosthetic Valves With a Balloon-Expandable Transcatheter Heart Valve

Presenter: John G. Webb

September 23, 2018

News Opinion Editor's Corner TCT 2017

My Takeaways From TCT 2017: Show Up, Keep It Civil, and Bring Your Best Self

Shelley Wood

November 22, 2017

Presentation TCT 2017

Hemodynamic Trends on Serial Echocardiograms after TAVR: Comprehensive 5-Year Analyses From PARTNER

Presenter: Pamela S. Douglas

November 01, 2017

Presentation TCT 2017

PARTNER 2A and SAPIEN 3 Cost-effectiveness: Cost-effectiveness of TAVR vs SAVR in Intermediate-Risk Patients With Aortic Stenosis

Presenter: Patrick W. Serruys, David J. Cohen

October 31, 2017

News Conference News TCT 2017

Live From Denver: TCT 2017, Day Two

Shelley Wood

October 31, 2017

Presentation TCT 2017

Important Clinical Lessons From the VIVID Registry and the PARTNER Experience

Presenter: John G. Webb

October 30, 2017

Presentation TCT 2017

The PARTNER 3 Low-risk Trial

Presenter: Michael J. Mack

October 30, 2017

Presentation TCT 2017

Viewpoint #1: PARTNER 2A and SURTAVI are Convincing TAVR is Preferred in ALL (Appropriate) Intermediate-Risk Patients

Presenter: Michael J. Reardon

October 30, 2017

Presentation TCT 2017

Take-home Messages and Closing Comments

Presenter: Amal Kumar Banerjee, Rabin dra Nath Chakraborty

October 29, 2017

Presentation TCT 2017

Clinical Case #4: A Complex and High-Risk PCI

Presenter: Anibal A. Damonte, Alejandro O. Palacios, Alejandro Cherro

October 29, 2017

Presentation TCT 2017

Resting Pd/Pa vs FFR for Predicting Coronary Events

Presenter: Gary S. Mintz, Seung-Jung Park, Jung-Min Ahn

October 29, 2017

Presentation TCT 2017

STEMI and Cardiogenic Shock With Comorbidities

Presenter: Ayman Abou El Magd, Mohamed Ahmed Sobhy, Mohamed Loutfi

October 29, 2017

Presentation TCT 2017

Case Presentation 6: BTK Intervention

Presenter: Sergey A. Abugov, Juan F. Granada, Zaza Kavteladze

October 29, 2017

Presentation TCT 2017

Debate: iFR as the Gold Standard Index!

Presenter: Gary S. Mintz, Seung-Jung Park, Justin E. Davies

October 29, 2017

Presentation TCT 2017

Case Presentation #2: Complication Made Simple - Managing Longitudinal Stent Distortion

Presenter: Amal Kumar Banerjee, Rabin dra Nath Chakraborty, Saujatya Chakraborty

October 29, 2017

Presentation TCT 2017

What Is the Future of Bioabsorbable Scaffolds?

Presenter: Anibal A. Damonte, Alejandro O. Palacios, Patrick W. Serruys

October 29, 2017

Advertisement

TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More

Prosthetic Valve Endocarditis Rate Similarly Low for TAVR vs SAVR

TCT 2018, Day Two: COAPT Prompts Round of Applause, Plus New Valve Insights

High Mortality but Durable Results With Valve-in-Valve TAVR

PARTNER VALVE-IN-VALVE: Late Follow-up After Treatment of Failing Surgical Aortic Bioprosthetic Valves With a Balloon-Expandable Transcatheter Heart Valve

My Takeaways From TCT 2017: Show Up, Keep It Civil, and Bring Your Best Self

Hemodynamic Trends on Serial Echocardiograms after TAVR: Comprehensive 5-Year Analyses From PARTNER

PARTNER 2A and SAPIEN 3 Cost-effectiveness: Cost-effectiveness of TAVR vs SAVR in Intermediate-Risk Patients With Aortic Stenosis

Live From Denver: TCT 2017, Day Two

Important Clinical Lessons From the VIVID Registry and the PARTNER Experience

The PARTNER 3 Low-risk Trial

Viewpoint #1: PARTNER 2A and SURTAVI are Convincing TAVR is Preferred in ALL (Appropriate) Intermediate-Risk Patients

Take-home Messages and Closing Comments

Clinical Case #4: A Complex and High-Risk PCI

Resting Pd/Pa vs FFR for Predicting Coronary Events

STEMI and Cardiogenic Shock With Comorbidities

Case Presentation 6: BTK Intervention

Debate: iFR as the Gold Standard Index!

Case Presentation #2: Complication Made Simple - Managing Longitudinal Stent Distortion

What Is the Future of Bioabsorbable Scaffolds?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content